Latest Breaking News On - Sabina packeiser - Page 1 : comparemela.com

Cytosurge AG: Cytosurge's CellEDIT Workflow, based on its Proprietary FluidFM® Technology, Receives Validation in Peer-Reviewed Publication

CellEDIT Service represents a novel workflow leveraging FluidFM-mediated intranuclear nanoinjection of CRISPR/Cas9 components into single cells.Control of the amount and stoichiometry of RNP complexes

Cytosurge's CellEDIT Workflow, based on its Proprietary

CellEDIT uses FluidFM for precise nuclear CRISPR/Cas9 injection, boosting efficiency by controlling RNP amounts, preserving traits in edited CHO-K1 cells..

Cytosurge's CellEDIT Workflow, based on its Proprietary FluidFM® Technology, Receives Validation in Peer-Reviewed Publication

New CRISPR/Cas9 license agreement for ERS Genomics and Cytosurge

/PRNewswire/ ERS Genomics Limited ( ERS ) is pleased to announce a new license agreement with Cytosurge AG ("Cytosurge"). This is a non-exclusive licensing.